Helicobacter hepaticus, a recently recognized bacterial pathogen, associated with chronic hepatitis and hepatocellular neoplasia in laboratory mice.
作者信息
Rice J M
机构信息
Laboratory of Comparative Carcinogenesis, National Cancer Institute, Frederick, Maryland, USA.
出版信息
Emerg Infect Dis. 1995 Oct-Dec;1(4):129-31. doi: 10.3201/eid0104.950404.
Abstract
摘要
相似文献
1
Helicobacter hepaticus, a recently recognized bacterial pathogen, associated with chronic hepatitis and hepatocellular neoplasia in laboratory mice.肝螺杆菌是一种最近才被认识的细菌病原体，与实验小鼠的慢性肝炎和肝细胞肿瘤形成有关。
Emerg Infect Dis. 1995 Oct-Dec;1(4):129-31. doi: 10.3201/eid0104.950404.
2
Evaluation of various oral antimicrobial formulations for eradication of Helicobacter hepaticus.评估多种口服抗菌制剂对肝螺杆菌的根除效果。
Lab Anim Sci. 1996 Apr;46(2):193-7.
3
4
5
[Role of Helicobacter species in hepatobiliary diseases].[幽门螺杆菌属在肝胆疾病中的作用]
Ugeskr Laeger. 2008 Jun 2;170(23):2010-5.
6
Six months' experience with a pharmacist-run Helicobacter pylori treatment clinic.药剂师管理的幽门螺杆菌治疗诊所的六个月经验
Am J Health Syst Pharm. 1996 Sep 1;53(17):2081-2. doi: 10.1093/ajhp/53.17.2081.
7
Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species.由一种新型幽门螺杆菌持续细菌感染引起的小鼠慢性活动性肝炎及相关肝脏肿瘤。
J Natl Cancer Inst. 1994 Aug 17;86(16):1222-7. doi: 10.1093/jnci/86.16.1222.
8
Review of successful treatment for Helicobacter species in laboratory mice.实验室小鼠中幽门螺杆菌成功治疗的综述。
Lab Anim. 2006 Apr;40(2):115-22. doi: 10.1258/002367706776319033.
9
Evaluation of a new bismuth-free triple therapy in nude mice and humans.新型无铋三联疗法在裸鼠和人体中的评估。
Eur J Gastroenterol Hepatol. 1995 Aug;7 Suppl 1:S31-4.
10
Evaluation of antibiotic therapies for eradication of Helicobacter hepaticus.评估用于根除肝螺杆菌的抗生素疗法。
Antimicrob Agents Chemother. 1995 Jun;39(6):1292-4. doi: 10.1128/AAC.39.6.1292.
引用本文的文献
1
Bacterial-Mediated Tumor Therapy: Old Treatment in a New Context.细菌介导的肿瘤治疗：旧疗法的新应用。
Adv Sci (Weinh). 2023 Apr;10(12):e2205641. doi: 10.1002/advs.202205641. Epub 2023 Mar 12.
2
Pathogenicity of Helicobacter ganmani in mice susceptible and resistant to infection with H. hepaticus.甘氏螺杆菌对肝螺杆菌感染易感和抗性小鼠的致病性。
Comp Med. 2015 Feb;65(1):15-22.
3
Association between Helicobacter spp. infections and hepatobiliary malignancies: a review.幽门螺杆菌属感染与肝胆恶性肿瘤之间的关联：一项综述
World J Gastroenterol. 2015 Feb 7;21(5):1414-23. doi: 10.3748/wjg.v21.i5.1414.
4
Inhibitory effect of Lactobacillus acidophilus on Helicobacter hepaticus in vitro.嗜酸乳杆菌体外抑制肝螺杆菌的作用。
World J Microbiol Biotechnol. 2013 Mar;29(3):499-504. doi: 10.1007/s11274-012-1203-2. Epub 2013 Jan 5.
5
Marked liver tumorigenesis by Helicobacter hepaticus requires perinatal exposure.肝螺杆菌引起的明显肝脏肿瘤发生需要围产期暴露。
Environ Health Perspect. 2008 Oct;116(10):1352-6. doi: 10.1289/ehp.11493. Epub 2008 Jun 13.
6
Characterization of a Helicobacter hepaticus putA mutant strain in host colonization and oxidative stress.肝螺杆菌putA突变株在宿主定殖和氧化应激中的特性分析
Infect Immun. 2008 Jul;76(7):3037-44. doi: 10.1128/IAI.01737-07. Epub 2008 May 5.
7
Serum antibodies to Helicobacter hepaticus and Helicobacter pylori in patients with chronic liver disease.慢性肝病患者中针对肝螺杆菌和幽门螺杆菌的血清抗体
Gut. 2000 Mar;46(3):410-4. doi: 10.1136/gut.46.3.410.
8
Cloning and expression of an immunogenic membrane-associated protein of Helicobacter hepaticus for use in an enzyme-linked immunosorbent assay.肝螺杆菌一种免疫原性膜相关蛋白的克隆与表达，用于酶联免疫吸附测定。
Clin Diagn Lab Immunol. 1999 Sep;6(5):745-50. doi: 10.1128/CDLI.6.5.745-750.1999.
9
Chronic active hepatitis induced by Helicobacter hepaticus in the A/JCr mouse is associated with a Th1 cell-mediated immune response.肝螺杆菌在A/JCr小鼠中诱导的慢性活动性肝炎与Th1细胞介导的免疫反应有关。
Infect Immun. 1998 Jul;66(7):3142-8. doi: 10.1128/IAI.66.7.3142-3148.1998.
本文引用的文献
1
Helicobacter pylori isolated from the domestic cat: public health implications.从家猫中分离出的幽门螺杆菌：对公共卫生的影响。
Infect Immun. 1994 Jun;62(6):2367-74. doi: 10.1128/iai.62.6.2367-2374.1994.
2
Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori.根除幽门螺杆菌后黏膜相关淋巴组织型原发性低度B细胞胃淋巴瘤的消退
Lancet. 1993 Sep 4;342(8871):575-7. doi: 10.1016/0140-6736(93)91409-f.
3
Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice.肝螺杆菌新种，一种从小鼠肝脏和肠黏膜刮片中分离出的微需氧菌。
J Clin Microbiol. 1994 May;32(5):1238-45. doi: 10.1128/jcm.32.5.1238-1245.1994.
4
Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species.由一种新型幽门螺杆菌持续细菌感染引起的小鼠慢性活动性肝炎及相关肝脏肿瘤。
J Natl Cancer Inst. 1994 Aug 17;86(16):1222-7. doi: 10.1093/jnci/86.16.1222.
5
Chronic active hepatitis in mice caused by Helicobacter hepaticus.由肝螺杆菌引起的小鼠慢性活动性肝炎。
Am J Pathol. 1994 Oct;145(4):959-68.
6
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group.幽门螺杆菌感染治愈后黏膜相关淋巴组织型原发性胃淋巴瘤的消退。MALT淋巴瘤研究小组。
Lancet. 1995 Jun 24;345(8965):1591-4. doi: 10.1016/s0140-6736(95)90113-2.
7
In-vitro hepatotoxic factor in Helicobacter hepaticus, H. pylori and other Helicobacter species.肝螺杆菌、幽门螺杆菌及其他螺杆菌属中的体外肝毒性因子。
J Med Microbiol. 1995 Jan;42(1):48-52. doi: 10.1099/00222615-42-1-48.
8
Evaluation of antibiotic therapies for eradication of Helicobacter hepaticus.评估用于根除肝螺杆菌的抗生素疗法。
Antimicrob Agents Chemother. 1995 Jun;39(6):1292-4. doi: 10.1128/AAC.39.6.1292.
9
Diagnostic assay for Helicobacter hepaticus based on nucleotide sequence of its 16S rRNA gene.基于肝螺杆菌16S rRNA基因核苷酸序列的诊断检测方法。
J Clin Microbiol. 1995 May;33(5):1344-7. doi: 10.1128/jcm.33.5.1344-1347.1995.
10
Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis.慢性感染和炎症过程作为癌症风险因素：一氧化氮在致癌作用中的可能作用。
Mutat Res. 1994 Mar 1;305(2):253-64. doi: 10.1016/0027-5107(94)90245-3.
Zotero 插件